| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 54.0664 | 58 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.9054 | 48 |
| GSM780709 | Untreated after 4 days (C3_1) | 59.4534 | 64 |
| GSM780719 | Untreated after 4 days (C1_2) | 55.5408 | 60 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.5329 | 43 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.5459 | 39 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.0192 | 49 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.7199 | 51 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 63.9651 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 57.8355 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.6158 | 47 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 52.1829 | 54 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.934 | 36 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.537 | 55 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.3014 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.0748 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.3167 | 52 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.9345 | 61 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.5774 | 57 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.8463 | 48 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.4806 | 47 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.6255 | 55 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.1941 | 52 |